Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 8
2008 19
2009 46
2010 54
2011 55
2012 53
2013 32
2014 44
2015 44
2016 33
2017 28
2018 38
2019 31
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

433 results
Results by year
Filters applied: . Clear all
Page 1
Prevention of venous thromboembolism in gynecologic oncology surgery.
Barber EL, Clarke-Pearson DL. Barber EL, et al. Gynecol Oncol. 2017 Feb;144(2):420-427. doi: 10.1016/j.ygyno.2016.11.036. Epub 2016 Nov 25. Gynecol Oncol. 2017. PMID: 27890280 Free PMC article. Review.
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA, Bodalia PN, Bryden PA, Davies PA, López-López JA, Okoli GN, Thom HH, Caldwell DM, Dias S, Eaton D, Higgins JP, Hollingworth W, Salisbury C, Savović J, Sofat R, Stephens-Boal A, Welton NJ, Hingorani AD. Sterne JA, et al. Health Technol Assess. 2017 Mar;21(9):1-386. doi: 10.3310/hta21090. Health Technol Assess. 2017. PMID: 28279251 Free PMC article. Review.
RESULTS: Apixaban (Eliquis(®), Bristol-Myers Squibb, USA; Pfizer, USA) [5 mg bd (twice daily)] was ranked as among the best interventions for stroke prevention in AF, and had the highest expected net benefit. ...
RESULTS: Apixaban (Eliquis(®), Bristol-Myers Squibb, USA; Pfizer, USA) [5 mg bd (twice daily)] was ranked as among the best in …
Trousseau's syndrome: cancer-associated thrombosis.
Ikushima S, Ono R, Fukuda K, Sakayori M, Awano N, Kondo K. Ikushima S, et al. Jpn J Clin Oncol. 2016 Mar;46(3):204-8. doi: 10.1093/jjco/hyv165. Epub 2015 Nov 6. Jpn J Clin Oncol. 2016. PMID: 26546690 Review.
The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants.
Leffert L, Butwick A, Carvalho B, Arendt K, Bates SM, Friedman A, Horlocker T, Houle T, Landau R, Dubois H, Fernando R, Houle T, Kopp S, Montgomery D, Pellegrini J, Smiley R, Toledo P; members of the SOAP VTE Taskforce. Leffert L, et al. Anesth Analg. 2018 Mar;126(3):928-944. doi: 10.1213/ANE.0000000000002530. Anesth Analg. 2018. PMID: 29099429
Venous thromboembolism is recognized as a leading cause of maternal death in the United States. Thromboprophylaxis has been highlighted as a key preventive measure to reduce venous thromboembolism-related maternal deaths. ...
Venous thromboembolism is recognized as a leading cause of maternal death in the United States. Thromboprophylaxis has been hi …
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis.
Dawwas GK, Brown J, Dietrich E, Park H. Dawwas GK, et al. Lancet Haematol. 2019 Jan;6(1):e20-e28. doi: 10.1016/S2352-3026(18)30191-1. Epub 2018 Dec 14. Lancet Haematol. 2019. PMID: 30558988
METHODS: We did a retrospective cohort analysis of data from the Truven Health MarketScan commercial and Medicare Supplement claims databases in the USA. ...
METHODS: We did a retrospective cohort analysis of data from the Truven Health MarketScan commercial and Medicare Supplement claims database …
433 results
Jump to page
Feedback